Sinocelltech Group Limited (SHA:688520)
52.97
+0.98 (1.88%)
Oct 27, 2025, 11:29 AM CST
Sinocelltech Group Revenue
Sinocelltech Group had revenue of 452.28M CNY in the quarter ending June 30, 2025, a decrease of -34.66%. This brings the company's revenue in the last twelve months to 2.18B, down -8.55% year-over-year. In the year 2024, Sinocelltech Group had annual revenue of 2.51B with 33.13% growth.
Revenue (ttm)
2.18B
Revenue Growth
-8.55%
P/S Ratio
10.62
Revenue / Employee
972.37K
Employees
2,277
Market Cap
23.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.51B | 625.36M | 33.13% |
| Dec 31, 2023 | 1.89B | 864.17M | 84.46% |
| Dec 31, 2022 | 1.02B | 888.78M | 661.33% |
| Dec 31, 2021 | 134.39M | 134.06M | 40,852.82% |
| Dec 31, 2020 | 328.17K | -2.31M | -87.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |